3D-QSAR comparative molecular field analysis on delta opioid receptor agonist SNC80 and its analogs

Journal of Molecular Graphics and Modelling

Volumn 24, Issue 1, 2005, Pages 25-33

  Peng, Youyi ^a   Keenan, Susan M ^a   Zhang, Qiang ^a   Welsh, William J ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Agonists; CoMFA; N4 protonated forms; Opioid receptors; SNC80

Indexed keywords

ACTIVATION ANALYSIS; BENZENE; PHYSIOLOGICAL MODELS; QUANTUM THEORY;

AGONISTS; COMFA; N4-PROTONATED FORMS; OPIOID RECEPTORS;

MOLECULAR DYNAMICS;

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; BENZYL DERIVATIVE; DELTA OPIATE RECEPTOR AGONIST; NITROGEN;

ARTICLE; ATOM; BINDING AFFINITY; CALCULATION; COMPARATIVE MOLECULAR FIELD ANALYSIS; IC 50; PHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTON TRANSPORT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; QUANTUM CHEMISTRY; STATISTICAL SIGNIFICANCE; VALIDATION PROCESS;

ANIMALS; BENZAMIDES; BINDING SITES; MODELS, CHEMICAL; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PIPERAZINES; PROTONS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RATS; RECEPTORS, OPIOID, DELTA; THERMODYNAMICS;

EID: 24944584700     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2005.05.001     Document Type: Article

References (35)

1. B.N. Dhawan, F. Cesselin, R. Raghubir, T. Reisine, P.B. Bradley, P.S. Portoghese, and M. Hamon International Union of Pharmacology. XII. Classification of opioid receptors Pharmacol. Rev. 48 1996 567 592
2. C.B. Pert, and S.H. Snyder Opiate receptor: demonstration in nervous tissue Science 179 1973 1011 1014
3. Y. Chen, A. Mestek, J. Liu, and L. Yu Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors Biochem. J. 295 3 1993 625 628
4. A. Goldstein, and A. Naidu Multiple opioid receptors: ligand selectivity profiles and binding site signatures Mol. Pharmacol. 36 1989 265 272
5. G.B. Stefano, P. Melchiorri, L. Negri, T.K. Hughes Jr., and B. Scharrer [d-Ala2]deltorphin I binding and pharmacological evidence for a special subtype of delta opioid receptor on human and invertebrate immune cells Proc. Natl. Acad. Sci. U.S.A. 89 1992 9316 9320
6. E.J. Bilsky, S.N. Calderon, T. Wang, R.N. Bernstein, P. Davis, V.J. Hruby, R.W. McNutt, R.B. Rothman, K.C. Rice, and F. Porreca SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist J. Pharmacol. Exp. Ther. 273 1995 359 366
7. P.Y. Cheng, D. Wu, J. Decena, Y. Soong, S. McCabe, and H.H. Szeto Opioid-induced stimulation of fetal respiratory activity by [d-Ala2]deltorphin I Eur. J. Pharmacol. 230 1993 85 88
8. M. Broccardo, and G. Improta Antidiarrheal and colonic antipropulsive effects of spinal and supraspinal administration of the natural delta opioid receptor agonist, [d-Ala2] deltorphin II, in the rat Eur. J. Pharmacol. 218 1992 69 73
9. M. Broccardo, G. Improta, and A. Tabacco Central effect of SNC 80, a selective and systemically active delta-opioid receptor agonist, on gastrointestinal propulsion in the mouse Eur. J. Pharmacol. 342 1998 247 251
10. P. Tejedor-Real, J.A. Mico, C. Smadja, R. Maldonado, B.P. Roques, and J. Gilbert-Rahola Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model Eur. J. Pharmacol. 354 1998 1 7
11. A. Saitoh, Y. Kimura, T. Suzuki, K. Kawai, H. Nagase, and J. Kamei Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents J. Pharmacol. Sci. 95 2004 374 380
12. D.J. Carr, C.H. Kim, B. deCosta, A.E. Jacobson, K.C. Rice, and J.E. Blalock Evidence for a delta-class opioid receptor on cells of the immune system Cell Immunol. 116 1988 44 51
13. D.J. Carr, B.R. DeCosta, C.H. Kim, A.E. Jacobson, V. Guarcello, K.C. Rice, and J.E. Blalock Opioid receptors on cells of the immune system: evidence for delta- and kappa-classes J. Endocrinol. 122 1989 161 168
14. C.J. Hille, S.H. Fox, Y.P. Maneuf, A.R. Crossman, and J.M. Brotchie Antiparkinsonian action of a delta opioid agonist in rodent and primate models of Parkinson's disease Exp. Neurol. 172 2001 189 198
15. S.N. Calderon, K.C. Rice, R.B. Rothman, F. Porreca, J.L. Flippen-Anderson, H. Kayakiri, H. Xu, K. Becketts, L.E. Smith, E.J. Bilsky, P. Davis, and R. Horvath Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alphaR)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3- methoxybenzyl]-N,N-diethylbenzamide (SNC80) and related novel nonpeptide delta opioid receptor ligands J. Med. Chem. 40 1997 695 704
16. M.S. Furness, X. Zhang, A. Coop, A.E. Jacobson, R.B. Rothman, C.M. Dersch, H. Xu, F. Porreca, and K.C. Rice Probes for narcotic receptor-mediated phenomena. 27. Synthesis and pharmacological evaluation of selective delta-opioid receptor agonists from 4-[(alphaR)-alpha-(2S,5R)-4-substituted-2,5- dimethyl-1-piperazinyl-3-methoxybenzyl]-N,N-diethylbenzamides and their enantiomers J. Med. Chem. 43 2000 3193 3196
17. Y. Katsura, X. Zhang, K. Homma, K.C. Rice, S.N. Calderon, R.B. Rothman, H.I. Yamamura, P. Davis, J.L. Flippen-Anderson, H. Xu, K. Becketts, E.J. Foltz, and F. Porreca Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists J. Med. Chem. 40 1997 2936 2947
18. J. Alfaro-Lopez, T. Okayama, K. Hosohata, P. Davis, F. Porreca, H.I. Yamamura, and V.J. Hruby Exploring the structure-activity relationships of inverted question mark1-(4-tert-butyl-3'-hydroxy)benzhydryl-4-benzylpiperazine (SL-3111), a high-affinity and selective delta-opioid receptor nonpeptide agonist ligand J. Med. Chem. 42 1999 5359 5368
19. J.B. Thomas, X.M. Herault, R.B. Rothman, R.N. Atkinson, J.P. Burgess, S.W. Mascarella, C.M. Dersch, H. Xu, J.L. Flippen-Anderson, C.F. George, and F.I. Carroll Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides J. Med. Chem. 44 2001 972 987
20. R. Schwyzer ACTH: a short introductory review Ann. N. Y. Acad. Sci. 297 1977 3 26
21. P.S. Portoghese Bivalent ligands and the message-address concept in the design of selective opioid receptor antagonists Trends Pharmacol. Sci. 10 1989 230 235
22. S.H. Snyder, and G.W. Pasternak Historical review: opioid receptors Trends Pharmacol. Sci. 24 2003 198 205
23. G. Dondio, S. Ronzoni, D.S. Eggleston, M. Artico, P. Petrillo, G. Petrone, L. Visentin, C. Farina, V. Vecchietti, and G.D. Clarke Discovery of a novel class of substituted pyrrolooctahydroisoquinolines as potent and selective delta opioid agonists, based on an extension of the message-address concept J. Med. Chem. 40 1997 3192 3198
24. F.H. Allen The Cambridge Structural Database: a quarter of a million crystal structures and rising Acta Crystallogr. B 58 2002 380 388
25. N. Plobeck, D. Delorme, Z.Y. Wei, H. Yang, F. Zhou, P. Schwarz, L. Gawell, H. Gagnon, B. Pelcman, R. Schmidt, S.Y. Yue, C. Walpole, W. Brown, E. Zhou, M. Labarre, K. Payza, S. St-Onge, A. Kamassah, P.E. Morin, D. Projean, J. Ducharme, and E. Roberts New diarylmethylpiperazines as potent and selective nonpeptidic delta opioid receptor agonists with increased in vitro metabolic stability J. Med. Chem. 43 2000 3878 3894
26. Spartan'02, Wavefunction, Inc., Irvine, CA.
27. Sybyl 6.8, Tripos, Inc., St. Louis, MO.
28. D.L. Harnett, and J.L. Murphy Introductory Statistical Analysis 1975 Addison-Wesley Publishing Co. Philippines p. 430
29. Y. Peng, S.M. Keenan, Q. Zhang, V. Kholodovych, and W.J. Welsh 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies J. Med. Chem. 48 2005 1620 1629
30. S. Funar-Timofei, and G. Schuurmann Comparative molecular field analysis (CoMFA) of anionic azo dye-fiber affinities. I. Gas-phase molecular orbital descriptors J. Chem. Inf. Comput. Sci. 42 2002 788 795
31. C.L. Waller, and G.R. Marshall Three-dimensional quantitative structure-activity relationship of angiotesin-converting enzyme and thermolysin inhibitors. II. A comparison of CoMFA models incorporating molecular orbital fields and desolvation free energies based on active-analog and complementary-receptor-field alignment rules J. Med. Chem. 36 1993 2390 2403
32. S.N. Calderon, R.B. Rothman, F. Porreca, J.L. Flippen-Anderson, R.W. McNutt, H. Xu, L.E. Smith, E.J. Bilsky, P. Davis, and K.C. Rice Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alphaR)-alpha- ((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N, N-diethylbenzamide (SNC 80): a highly selective, nonpeptide delta opioid receptor agonist J. Med. Chem. 37 1994 2125 2128
33. Z.Y. Wei, W. Brown, B. Takasaki, N. Plobeck, D. Delorme, F. Zhou, H. Yang, P. Jones, L. Gawell, H. Gagnon, R. Schmidt, S.Y. Yue, C. Walpole, K. Payza, S. St-Onge, M. Labarre, C. Godbout, A. Jakob, J. Butterworth, A. Kamassah, P.E. Morin, D. Projean, J. Ducharme, and E. Roberts N,N-Diethyl-4-(phenylpiperidin-4-ylidenemethyl)benzamide: a novel, exceptionally selective, potent delta opioid receptor agonist with oral bioavailability and its analogues J. Med. Chem. 43 2000 3895 3905
34. M. Valiquette, H.K. Vu, S.Y. Yue, C. Wahlestedt, and P. Walker Involvement of Trp-284, Val-296, and Val-297 of the human delta-opioid receptor in binding of delta-selective ligands J. Biol. Chem. 271 1996 18789 18796
35. M.C. Pepin, S.Y. Yue, E. Roberts, C. Wahlestedt, and P. Walker Novel "restoration of function" mutagenesis strategy to identify amino acids of the delta-opioid receptor involved in ligand binding J. Biol. Chem. 272 1997 9260 9267